Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 13;13(5):1642.
doi: 10.3390/nu13051642.

The Mesencephalic Trigeminal Nucleus Controls Food Intake and Body Weight via Hindbrain POMC Projections

Affiliations

The Mesencephalic Trigeminal Nucleus Controls Food Intake and Body Weight via Hindbrain POMC Projections

Samantha M Fortin et al. Nutrients. .

Abstract

The mesencephalic trigeminal nucleus (Mes5) processes oral sensory-motor information, but its role in the control of energy balance remains unexplored. Here, using fluorescent in situ hybridization, we show that the Mes5 expresses the melanocortin-4 receptor. Consistent with MC4R activation in other areas of the brain, we found that Mes5 microinjection of the MC4R agonist melanotan-II (MTII) suppresses food intake and body weight in the mouse. Furthermore, NTS POMC-projecting neurons to the Mes5 can be chemogenetically activated to drive a suppression in food intake. Taken together, these findings highlight the Mes5 as a novel target of melanocortinergic control of food intake and body weight regulation, although elucidating the endogenous role of this circuit requires future study. While we observed the sufficiency of Mes5 MC4Rs for food intake and body weight suppression, these receptors do not appear to be necessary for food intake or body weight control. Collectively, the data presented here support the functional relevance of the NTS POMC to Mes5 projection pathway as a novel circuit that can be targeted to modulate food intake and body weight.

Keywords: MC4R; melanocortin; obesity.

PubMed Disclaimer

Conflict of interest statement

M.R.H. has received research support, not used in the current studies, from investigator-initiated sponsored proposals from Eli Lilly & Co. and Boehringer-Ingelheim. H.J.G. has received research support, not used in the current studies, from an investigator-initiated sponsored proposal from Pfizer. The remaining authors have nothing to disclose.

Figures

Figure 1
Figure 1
Fluorescence in-situ hybridization images demonstrating expression of the MC4R on Mes5 neurons. Colocalization indicates expression of the MC4R (yellow) on Mes5 parvalbumin-expressing neurons (magenta) that border the dopamine beta-hydroxylase-expressing neurons (green) of the locus coeruleus. 4V = fourth ventricle, scp = superior cerebellar peduncle. Image corresponds to plate level 76 of Paxinos and Watson’s Mouse Brain Atlas, fourth edition.
Figure 2
Figure 2
Pharmacological activation of Mes5 MC4Rs suppresses food intake and body weight in male and female mice. (A,B) Bilateral Mes5 infusion of the MC3/4R agonist MTII (0.05 nmol) suppresses cumulative chow intake at 3, 6, and 24 h post-manipulation and (C,D) 24 h body weight change relative to vehicle treatment in male and female mice. Data represent means ±SEM; Paired Student’s t-tests: * = p < 0.05, ** = p < 0.01, *** = p < 0.001; n = 14 males, n = 9 females.
Figure 3
Figure 3
The Mes5 MC4R is not necessary for food intake or body weight control. Bilateral Mes5 infusion of the MC3/4R antagonist SHU9119 (60 pmol) does not impact cumulative chow intake in male (A) or female (B) mice. 24 h body weight is also not impacted by Mes5 directed infusion of SHU9119 in male ((C); n = 12) or female ((D); n = 8) mice. Cumulative 48-hr chow intake (E) and body weight (F) over 16 days is similar for Mes5 MC4R knockout (AAV-Cre-GFP; n = 11) and control (AAV-GFP; n = 7) mice. Data represent means ± SEM; Paired Student’s t-tests.
Figure 4
Figure 4
Chemogenic activation of NTS POMC projections acutely suppresses food intake. (A) In NTShM3Dq male, but not NTSmCherry control male mice, injection of CNO (1 mg/kg; IP) suppresses 3 and 6 h cumulative chow intake but not 1 or 24 h food intake or (B) 24 h body weight change relative to vehicle treatment. (C) In NTShM3Dq female, but not NTSmCherry control female mice, CNO suppresses 3 and 6 h chow intake but not 1 or 24 h food intake or (D) 24 h body weight change relative to vehicle treatment. All data represent means ± SEM; Paired Student’s t-tests: * = p < 0.05, ** = p < 0.01; n = 10 male NTShM3Dq and n = 7 male NTSmCherry, n = 11 female NTShM3Dq and n = 5 female NTSmCherry.
Figure 5
Figure 5
Chemogenic activation of NTS POMC projections to the Mes5 acutely suppresses food intake. (A) In NTShM3Dq mice, but not NTSmCherry control mice, injection of CNO (1 mM) into the bilateral Mes5 suppresses 1, 3, and 6 h cumulative chow intake but not 24 h food intake in NTS or (B) 24 h body weight change relative to vehicle treatment. All data represent means ± SEM; Paired Student’s t-tests: * = p < 0.05; n = 9 NTShM3Dq and n = 9 NTSmCherry.

Similar articles

Cited by

References

    1. Berthoud H.R. Multiple neural systems controlling food intake and body weight. Neurosci. Biobehav. Rev. 2002;26:393–428. doi: 10.1016/S0149-7634(02)00014-3. - DOI - PubMed
    1. Morton G.J., Cummings D.E., Baskin D.G., Barsh G.S., Schwartz M.W. Central nervous system control of food intake and body weight. Nature. 2006;443:289–295. doi: 10.1038/nature05026. - DOI - PubMed
    1. Saper C.B., Chou T.C., Elmquist J.K. The need to feed: Homeostatic and hedonic control of eating. Neuron. 2002;36:199–211. doi: 10.1016/S0896-6273(02)00969-8. - DOI - PubMed
    1. Waterson M.J., Horvath T.L. Neuronal Regulation of Energy Homeostasis: Beyond the Hypothalamus and Feeding. Cell Metab. 2015;22:962–970. doi: 10.1016/j.cmet.2015.09.026. - DOI - PubMed
    1. Williams D.L., Kaplan J.M., Grill H.J. The role of the dorsal vagal complex and the vagus nerve in feeding effects of melanocortin-3/4 receptor stimulation. Endocrinology. 2000;141:1332–1337. doi: 10.1210/endo.141.4.7410. - DOI - PubMed

Substances